|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dvorak HF: Tumors: Wounds that do not
heal. Similarities between tumor stroma generation and wound
healing. N Engl J Med. 315:1650–1659. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Whatcott CJ, Diep CH, Jiang P, Watanabe A,
LoBello J, Sima C, Hostetter G, Shepard HM, Von Hoff DD and Han H:
Desmoplasia in primary tumors and metastatic lesions of pancreatic
cancer. Clin Cancer Res. 21:3561–3568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stylianopoulos T, Martin JD, Chauhan VP,
Jain SR, Diop-Frimpong B, Bardeesy N, Smith BL, Ferrone CR,
Hornicek FJ, Boucher Y, et al: Causes, consequences, and remedies
for growth-induced solid stress in murine and human tumors. Proc
Natl Acad Sci USA. 109:15101–15108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chauhan VP, Boucher Y, Ferrone CR, Roberge
S, Martin JD, Stylianopoulos T, Bardeesy N, DePinho RA, Padera TP,
Munn LL and Jain RK: Compression of pancreatic tumor blood vessels
by hyaluronan is caused by solid stress and not interstitial fluid
pressure. Cancer Cell. 26:14–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Provenzano PP, Cuevas C, Chang AE, Goel
VK, Von Hoff DD and Hingorani SR: Enzymatic targeting of the stroma
ablates physical barriers to treatment of pancreatic ductal
adenocarcinoma. Cancer Cell. 21:418–429. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Apte MV, Haber PS, Applegate TL, Norton
ID, McCaughan GW, Korsten MA, Pirola RC and Wilson JS: Periacinar
stellate shaped cells in rat pancreas: Identification, isolation,
and culture. Gut. 43:128–133. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Phillips PA, McCarroll JA, Park S, Wu MJ,
Pirola R, Korsten M, Wilson JS and Apte MV: Rat pancreatic stellate
cells secrete matrix metalloproteinases: Implications for
extracellular matrix turnover. Gut. 52:275–282. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Apte MV and Wilson JS: Dangerous liaisons:
Pancreatic stellate cells and pancreatic cancer cells. J
Gastroenterol Hepatol. 27 Suppl 2:S69–S74. 2012. View Article : Google Scholar
|
|
10
|
Bailey JM, Swanson BJ, Hamada T, Eggers
JP, Singh PK, Caffery T, Ouellette MM and Hollingsworth MA: Sonic
hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer
Res. 14:5995–6004. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang RF, Moore T, Arumugam T,
Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD:
Cancer-associated stromal fibroblasts promote pancreatic tumor
progression. Cancer Res. 68:918–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fosslien E: Molecular pathology of
cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci. 30:3–21.
2000.PubMed/NCBI
|
|
13
|
Schlosser W, Schlosser S, Ramadani M,
Gansauge F, Gansauge S and Beger HG: Cyclooxygenase-2 is
overexpressed in chronic pancreatitis. Pancreas. 25:26–30. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tucker ON, Dannenberg AJ, Yang EK, Zhang
F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT
and Fahey TJ III: Cyclooxygenase-2 expression is up-regulated in
human pancreatic cancer. Cancer Res. 59:987–990. 1999.PubMed/NCBI
|
|
15
|
Kokawa A, Kondo H, Gotoda T, Ono H, Saito
D, Nakadaira S, Kosuge T and Yoshida S: Increased expression of
cyclooxygenase-2 in human pancreatic neoplasms and potential for
chemoprevention by cyclooxygenase inhibitors. Cancer. 91:333–338.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koshiba T, Hosotani R, Miyamoto Y, Wada M,
Lee JU, Fujimoto K, Tsuji S, Nakajima S, Doi R and Imamura M:
Immunohistochemical analysis of cyclooxygenase-2 expression in
pancreatic tumors. Int J Pancreatol. 26:69–76. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Merati K, Siadaty Said M, Andea A, Sarkar
F, Ben-Josef E, Mohammad R, Philip P, Shields AF, Vaitkevicius V,
Grignon DJ and Adsay NV: Expression of inflammatory modulator COX-2
in pancreatic ductal adenocarcinoma and its relationship to
pathologic and clinical parameters. Am J Clin Oncol. 24:447–452.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maitra A, Ashfaq R, Gunn CR, Rahman A, Yeo
CJ, Sohn TA, Cameron JL, Hruban RH and Wilentz RE: Cyclooxygenase 2
expression in pancreatic adenocarcinoma and pancreatic
intraepithelial neoplasia: An immunohistochemical analysis with
automated cellular imaging. Am J Clin Pathol. 118:194–201. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Philip B, Roland CL, Daniluk J, Liu Y,
Chatterjee D, Gomez SB, Ji B, Huang H, Wang H, Fleming JB, et al: A
high-fat diet activates oncogenic Kras and COX2 to induce
development of pancreatic ductal adenocarcinoma in mice.
Gastroenterology. 145:1449–1458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Charo C, Holla V, Arumugam T, Hwang R,
Yang P, Dubois RN, Menter DG, Logsdon CD and Ramachandran V:
Prostaglandin E2 regulates pancreatic stellate cell activity via
the EP4 receptor. Pancreas. 42:467–474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kubatka P, Kalická K, Bojková B, Ahlers I,
Ahlersová E and Péč M: Neoplastic effect of indomethacin in
N-methyl-N-nitrosourea induced mammary carcinogenesis in female
rats. Klin Onkol. 25:359–363. 2012.(In Slovak). PubMed/NCBI
|
|
22
|
Lange A, Gustke H, Glassmeier G, Heine M,
Zangemeister-Wittke U, Schwarz JR, Schumacher U and Lange T:
Neuronal differentiation by indomethacin and IBMX inhibits
proliferation of small cell lung cancer cells in vitro. Lung
Cancer. 74:178–187. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Groot DJ, van der Deen M, Le TK,
Regeling A, de Jong S and de Vries EG: Indomethacin induces
apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant
small-cell lung cancer cells overexpressing MRP1. Br J Cancer.
97:1077–1083. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Das A, Banik NL and Ray SK:
Methylprednisolone and indomethacin inhibit oxidative stress
mediated apoptosis in rat C6 glioblastoma cells. Neurochem Res.
32:1849–1856. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han L, Peng B, Ma Q, Ma J, Li J, Li W,
Duan W, Chen C, Liu J, Xu Q, et al: Indometacin ameliorates high
glucose-induced proliferation and invasion via modulation of
e-cadherin in pancreatic cancer cells. Curr Med Chem. 20:4142–4152.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao Z, Wang X, Wu K, Zhao Y and Hu G:
Pancreatic stellate cells increase the invasion of human pancreatic
cancer cells through the stromal cell-derived factor-1/CXCR4 axis.
Pancreatology. 10:186–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bachem MG, Schneider E, Gross H,
Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A and
Adler G: Identification, culture, and characterization of
pancreatic stellate cells in rats and humans. Gastroenterology.
115:421–432. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rhim AD, Oberstein PE, Thomas DH, Mirek
ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP,
Tattersall IW, et al: Stromal elements act to restrain, rather than
support, pancreatic ductal adenocarcinoma. Cancer Cell. 25:735–747.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Özdemir BC, Pentcheva-Hoang T, Carstens
JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C,
Novitskiy SV, et al: Depletion of carcinoma-associated fibroblasts
and fibrosis induces immunosuppression and accelerates pancreas
cancer with reduced survival. Cancer Cell. 25:719–734. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pandol S, Edderkaoui M, Gukovsky I, Lugea
A and Gukovskaya A: Desmoplasia of pancreatic ductal
adenocarcinoma. Clin Gastroenterol Hepatol. 7 11 Suppl:S44–S47.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schober M, Jesenofsky R, Faissner R,
Weidenauer C, Hagmann W, Michl P, Heuchel RL, Haas SL and Löhr JM:
Desmoplasia and chemoresistance in pancreatic cancer. Cancers.
6:2137–2154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jain RK: Antiangiogenesis strategies
revisited: From starving tumors to alleviating hypoxia. Cancer
Cell. 26:605–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sherman MH, Yu RT, Engle DD, Ding N,
Atkins AR, Tiriac H, Collisson EA, Connor F, Van Dyke T, Kozlov S,
et al: Vitamin D receptor-mediated stromal reprogramming suppresses
pancreatitis and enhances pancreatic cancer therapy. Cell.
159:80–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Froeling FE, Feig C, Chelala C, Dobson R,
Mein CE, Tuveson DA, Clevers H, Hart IR and Kocher HM: Retinoic
acid-induced pancreatic stellate cell quiescence reduces paracrine
Wnt-β-catenin signaling to slow tumor progression.
Gastroenterology. 141(1486–1497): e1–e14. 2011.
|
|
36
|
Okami J, Yamamoto H, Fujiwara Y, Tsujie M,
Kondo M, Noura S, Oshima S, Nagano H, Dono K, Umeshita K, et al:
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Clin Cancer Res. 5:2018–2024. 1999.PubMed/NCBI
|
|
37
|
Yip-Schneider MT, Barnard DS, Billings SD,
Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS
and Sweeney CJ: Cyclooxygenase-2 expression in human pancreatic
adenocarcinomas. Carcinogenesis. 21:139–146. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Colby JK, Klein RD, McArthur MJ, Conti CJ,
Kiguchi K, Kawamoto T, Riggs PK, Pavone AI, Sawicki J and Fischer
SM: Progressive metaplastic and dysplastic changes in mouse
pancreas induced by cyclooxygenase-2 overexpression. Neoplasia.
10:782–796. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aoki H, Ohnishi H, Hama K, Shinozaki S,
Kita H, Osawa H, Yamamoto H, Sato K, Tamada K and Sugano K:
Cyclooxygenase-2 is required for activated pancreatic stellate
cells to respond to proinflammatory cytokines. Am J Physiol Cell
Physiol. 292:C259–C268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gong J, Xie J, Bedolla R, Rivas P,
Chakravarthy D, Freeman JW, Reddick R, Kopetz S, Peterson A, Wang
H, et al: Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective
management of pancreatic cancer. Clin Cancer Res. 20:1259–1273.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pomianowska E, Sandnes D, Grzyb K,
Schjølberg AR, Aasrum M, Tveteraas IH, Tjomsland V, Christoffersen
T and Gladhaug IP: Inhibitory effects of prostaglandin E2 on
collagen synthesis and cell proliferation in human stellate cells
from pancreatic head adenocarcinoma. BMC Cancer. 14:4132014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pessetto ZY, Weir SJ, Sethi G, Broward MA
and Godwin AK: Drug repurposing for gastrointestinal stromal tumor.
Mol Cancer Ther. 12:1299–1309. 2013. View Article : Google Scholar : PubMed/NCBI
|
